- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 403/04
Total number of patents in this class: 7386
10-year publication summary
|
566
|
550
|
538
|
581
|
594
|
543
|
497
|
558
|
406
|
224
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5830 |
150 |
| Bristol-myers Squibb Company | 4878 |
122 |
| Novartis AG | 10847 |
111 |
| Boehringer Ingelheim International GmbH | 4656 |
90 |
| Janssen Pharmaceutica N.V. | 3395 |
88 |
| AstraZeneca AB | 2920 |
80 |
| Bayer AG | 3329 |
77 |
| F. Hoffmann-La Roche AG | 7930 |
75 |
| Syngenta Crop Protection AG | 6045 |
73 |
| Merck Sharp & Dohme LLC | 3750 |
69 |
| Takeda Pharmaceutical Company Limited | 2714 |
68 |
| LG Chem, Ltd. | 17620 |
67 |
| Dana-Farber Cancer Institute, Inc. | 2567 |
64 |
| Hoffmann-La Roche Inc. | 3414 |
60 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
59 |
| Genentech, Inc. | 3971 |
56 |
| Vertex Pharmaceuticals Incorporated | 1599 |
54 |
| Araxes Pharma LLC | 91 |
49 |
| Abbvie Inc. | 1802 |
46 |
| Syngenta Participations AG | 1903 |
45 |
| Other owners | 5883 |